Follow the 바이넥스 share price and the full management transaction log of the company, a listed equity based in South Korea. Shares are listed on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 바이넥스 has published 38 public disclosures. Market capitalisation: €229bn. The latest transaction was disclosed on 3 July 2026 (Other). Among the most active insiders: 더에이블. All data is accessible without an account.
38
Insider Decl.
n/a
Thresholds
n/a
10 ops.
Buy Volume
n/a
4 ops.
Sell Volume
Fundamental score
Ranked 26,725 of 29,156 companies
19.9
score / 100
Value
17
Quality
23
FCF yld-20%
Earn yld-1.4%
EV/EBITDA25.8x
ROE·
Gross mgn27%
Net mgn-1.9%
Debt/EBITDA7.7x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
바이넥스 is a healthcare and pharmaceutical company listed on the XKRX market. It specializes in the development and manufacturing of pharmaceutical products.